Christoph Ruwwe-Glosenkamp
Overview
Explore the profile of Christoph Ruwwe-Glosenkamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demichev V, Tober-Lau P, Nazarenko T, Lemke O, Kaur Aulakh S, Whitwell H, et al.
PLOS Digit Health
. 2023 Feb;
1(1):e0000007.
PMID: 36812516
Global healthcare systems are challenged by the COVID-19 pandemic. There is a need to optimize allocation of treatment and resources in intensive care, as clinically established risk assessments such as...
2.
Kurth F, Helbig E, Lippert L, Thibeault C, Barbone G, Eckart M, et al.
J Glob Antimicrob Resist
. 2022 Dec;
32:44-47.
PMID: 36572146
Objectives: C-C-chemokine receptors (CCRs) are expressed on a variety of immune cells and play an important role in many immune processes, particularly leukocyte migration. Comprehensive preclinical research demonstrated CCR2/CCR5-dependent pathways...
3.
Steinbeis F, Knape P, Mittermaier M, Helbig E, Tober-Lau P, Thibeault C, et al.
Respir Med
. 2022 Sep;
202:106968.
PMID: 36081267
Background: Cardiopulmonary Exercise Testing (CPET) provides a comprehensive assessment of pulmonary, cardiovascular and musculosceletal function. Reduced CPET performance could be an indicator for chronic morbidity after COVID-19. Methods: Patients ≥18...
4.
Lenga P, Grah C, Ruwwe-Glosenkamp C, Saccomanno J, Ruckert J, Eggeling S, et al.
Respiration
. 2022 Jul;
101(9):823-832.
PMID: 35785772
Background: Robust clinical evidence on the efficacy and safety of endoscopic lung volume reduction (ELVR) with one-way valves in patients with severe lung emphysema with chronic hypercapnic respiratory failure is...
5.
Steinbeis F, Thibeault C, Doellinger F, Ring R, Mittermaier M, Ruwwe-Glosenkamp C, et al.
Respir Med
. 2021 Dec;
191:106709.
PMID: 34871947
Introduction: Prospective and longitudinal data on pulmonary injury over one year after acute coronavirus disease 2019 (COVID-19) are sparse. We aim to determine reductions in pulmonary function and respiratory related...
6.
Saccomanno J, Ruwwe-Glosenkamp C, Neumann K, Doellinger F, Lenga P, Pappe E, et al.
Respiration
. 2021 Dec;
101(4):408-416.
PMID: 34864739
Background: Endobronchial valve therapy has proven to reduce lung hyperinflation and decrease disease burden in patients with severe lung emphysema. Exclusion of collateral ventilation (CV) of the targeted lobe by...
7.
Hofmann M, Fluhr J, Ruwwe-Glosenkamp C, Stevanovic K, Bergmann K, Zuberbier T
Clin Transl Allergy
. 2021 Aug;
11(6):e12047.
PMID: 34429872
Purpose Of Review: Atopy is defined as the genetic predisposition to react with type I allergic diseases such as food-, skin-, and respiratory allergies. Distinct molecular mechanisms have been described,...
8.
Demichev V, Tober-Lau P, Lemke O, Nazarenko T, Thibeault C, Whitwell H, et al.
Cell Syst
. 2021 Jun;
12(8):780-794.e7.
PMID: 34139154
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection to severe organ damage and death. We characterized the time-dependent progression of the disease in 139 COVID-19 inpatients...
9.
Doehn J, Tabeling C, Biesen R, Saccomanno J, Madlung E, Pappe E, et al.
Infection
. 2021 Apr;
49(4):757-762.
PMID: 33825125
Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Type I interferons are important in the defense of viral infections. Recently, neutralizing IgG...
10.
Lenga P, Ruwwe-Glosenkamp C, Grah C, Pfannschmidt J, Ruckert J, Eggeling S, et al.
ERJ Open Res
. 2021 Feb;
7(1).
PMID: 33532454
Background: Endoscopic lung volume reduction (ELVR) with valves has been suggested to be the key strategy for patients with severe emphysema and concomitant low diffusing capacity of the lung for...